← back to search

Patrick J. Paddison

California Institute for Regenerative Medicine ·
Area of research
Cell Biology · Molecular Biology
Research interest
Research interests include Biology, YAP1, Hippo signaling pathway, Cancer research, Mutant, and CRISPR.
h-index
citations
822
works
11
NIH funding
primary concept
email

Recent publications

A modular CRISPR screen identifies individual and combination pathways contributing to HIV-1 latency
PLoS Pathogens 2023cited by 28position: middledoi
Both YAP1-MAML2 and constitutively active YAP1 drive the formation of tumors that resemble NF2 mutant meningiomas in mice
Genes & Development 2022cited by 51position: middledoi
MODL-36. EXPRESSION OF YAP1-MAML2 AND CONSTITUTIVELY ACTIVE YAP1 DRIVE THE FORMATION OF MENINGIOMA-LIKE TUMORS IN MICE THAT RESEMBLE NF2-MUTANT MENINGIOMAS
Neuro-Oncology 2022cited by 1position: middledoi
Both YAP1-MAML2 and constitutively active YAP1 drive the formation of tumors that resemble NF2-mutant meningiomas in mice
bioRxiv (Cold Spring Harbor Laboratory) 2022cited by 0position: middledoi
Comparison of tumor-associated YAP1 fusions identifies a recurrent set of functions critical for oncogenesis
Genes & Development 2020cited by 88position: middledoi
Histone deposition pathways determine the chromatin landscapes of H3.1 and H3.3 K27M oncohistones
eLife 2020cited by 69position: middledoi
Spontaneous Tumor Regression in Tasmanian Devils Associated with <i>RASL11A</i> Activation
Genetics 2020cited by 32position: middledoi
Transcription elongation factors represent in vivo cancer dependencies in glioblastoma
Nature 2017cited by 203position: middledoi
Screen for reactivation of MeCP2 on the inactive X chromosome identifies the BMP/TGF-β superfamily as a regulator of XIST expression
Proceedings of the National Academy of Sciences 2017cited by 69position: middledoi
Genome-wide CRISPR-Cas9 Screens Reveal Loss of Redundancy between PKMYT1 and WEE1 in Glioblastoma Stem-like Cells
Cell Reports 2015cited by 206position: lastdoi
A High-Content Small Molecule Screen Identifies Sensitivity of Glioblastoma Stem Cells to Inhibition of Polo-Like Kinase 1
PLoS ONE 2013cited by 75position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Frank Szulzewsky · Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa4 papers (2020–2022)Eric C. Holland · Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa4 papers (2020–2022)Taranjit S. Gujral · Queen's University4 papers (2020–2022)Patrick J. Cimino · Southwestern Medical Center4 papers (2020–2022)Damian A. Almiron Bonnin · Dartmouth College3 papers (2022–2022)Philipp Sievers · German Cancer Research Center3 papers (2022–2022)Aleena Arakaki · Fred Hutch Cancer Center3 papers (2022–2022)Felix Sahm · Heidelberg (Poland)3 papers (2022–2022)Derek H. Janssens · Van Andel Institute2 papers (2020–2023)Christina M. Lockwood · University of Washington1 papers (2020–2020)Lisa C. Wallace · Cleveland Clinic Lerner College of Medicine1 papers (2017–2017)Stefan H. Stricker · Ludwig-Maximilians-Universität München1 papers (2013–2013)Brian B. Liau · Broad Institute1 papers (2017–2017)Christopher G. Hubert · University Hospitals Cleveland Medical Center1 papers (2017–2017)Michael P. Meers · Washington University in St. Louis1 papers (2020–2020)Elaine A. Ostrander · National Institutes of Health1 papers (2020–2020)Claire King · Cancer Research UK Cambridge Center1 papers (2020–2020)Amanda R. Stahlke · University of Idaho1 papers (2020–2020)Jay F. Sarthy · Seattle Children's Hospital1 papers (2020–2020)Deobrat Dixit · Cleveland Clinic1 papers (2017–2017)